Costs associated with community acquired pneumonia in France
Author:
Funder
Pfizer France
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Link
http://link.springer.com/article/10.1007/s10198-017-0900-z/fulltext.html
Reference26 articles.
1. Torres, A., Peetermans, W.E., Viegi, G., Blasi, F.: Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 68(11), 1057–1065 (2013)
2. Vila-Corcoles, A., Ochoa-Gondar, O., Rodriguez-Blanco, T., Raga-Luria, X., Gomez-Bertomeu, F.: EPIVAC study group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir. Med. 103(2), 309–316 (2009)
3. Trotter, C.L., Stuart, J.M., George, R., et al.: Increasing hospital admissions for pneumonia, England. Emerg. Infect. Dis. 14, 72733 (2008)
4. Welte, T., Torres, A., Nathwani, D.: Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67, 71–79 (2012)
5. Casez, P., Fauconnier, J., Jorgensen, L., Gutterman, E.M., Gray, S., Munson, S., Dartois, N., Gaillat, J.: Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Médecine et Maladies Infectieuses 45, 446–455 (2015)
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hospital Burden of All-Cause Pneumonia and Nonbacteremic Pneumococcal Pneumonia in Adults in France Between 2013 and 2019;Open Forum Infectious Diseases;2024-06-28
2. Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France;European Journal of Public Health;2023-12-07
3. Delayed diagnosis of pneumonia in the emergency department: factors associated and prognosis;Frontiers in Medicine;2023-05-12
4. Sospecha de infección bronquial y pulmonar aguda en el paciente inmunocompetente (exceptuando la COVID-19);EMC - Tratado de Medicina;2022-12
5. All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain;Expert Review of Pharmacoeconomics & Outcomes Research;2022-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3